SEARCH

SEARCH BY CITATION

References

  • Akira S. and Takeda K. (2004) Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499511.
  • Aleshin S. and Reiser G. (2013) Role of the peroxisome proliferator-activated receptors (PPAR)-α, β/δ and γ in regulation of reactive oxygen species signaling in brain. Biol. Chem. 394, 15531570.
  • Aleshin S., Grabeklis S., Hanck T., Sergeeva M. and Reiser G. (2009) Peroxisome proliferator-activated receptor (PPAR)-γ positively controls and PPARα negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARβ/δ via mutual control of PPAR expression levels. Mol. Pharmacol. 76, 414424.
  • Aleshin S., Strokin M., Sergeeva M. and Reiser G. (2013) Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ- dependent molecular pathways in neurodegenerative diseases; review and novel hypotheses. Neurochem. Int. 63, 322330.
  • Anderson P. (2010) Post-transcriptional regulons coordinate the initiation and resolution of inflammation. Nat. Rev. Immunol. 10, 2435.
  • Bansal K., Kapoor N., Narayana Y., Puzo G., Gilleron M. and Balaji K. N. (2009) PIM2 Induced COX-2 and MMP-9 expression in macrophages requires PI3K and Notch1 signaling. PLoS ONE 4, e4911.
  • Bensinger S. J. and Tontonoz P. (2008) Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature 454, 470477.
  • Bernardo A. and Minghetti L. (2008) Regulation of glial cell functions by PPAR-γ natural and synthetic agonists. PPAR Res. 2008, 864140.
  • Borders A. S., de Almeida L., Van Eldik L. J. and Watterson D. M. (2008) The p38α mitogen-activated protein kinase as a central nervous system drug discovery target. BMC Neurosci. 9(Suppl 2), S12.
  • Borysiewicz E., Fil D. and Konat G. W. (2009) Rho proteins are negative regulators of TLR2, TLR3, and TLR4 signaling in astrocytes. J. Neurosci. Res. 87, 15651572.
  • Bowman C. C., Rasley A., Tranguch S. L. and Marriott I. (2003) Cultured astrocytes express toll-like receptors for bacterial products. Glia 43, 281291.
  • Burgermeister E. and Seger R. (2008) PPARγ and MEK interactions in cancer. PPAR Res. 2008, 309469.
  • Burns K. A. and Vanden Heuvel J. P. (2007) Modulation of PPAR activity via phosphorylation. Biochim. Biophys. Acta 1771, 952960.
  • Carpentier P. A., Begolka W. S., Olson J. K., Elhofy A., Karpus W. J. and Miller S. D. (2005) Differential activation of astrocytes by innate and adaptive immune stimuli. Glia 49, 360374.
  • Chico L. K., Van Eldik L. J. and Watterson D. M. (2009) Targeting protein kinases in central nervous system disorders. Nat. Rev. Drug Discov. 8, 892909.
  • Edwards D. R. and Mahadevan L. C. (1992) Protein synthesis inhibitors differentially superinduce c-fos and c-jun by three distinct mechanisms: lack of evidence for labile repressors. EMBO J. 11, 24152424.
  • Farina C., Krumbholz M., Giese T., Hartmann G., Aloisi F. and Meinl E. (2005) Preferential expression and function of Toll-like receptor 3 in human astrocytes. J. Neuroimmunol. 159, 1219.
  • Farina C., Aloisi F. and Meinl E. (2007) Astrocytes are active players in cerebral innate immunity. Trends Immunol. 28, 138145.
  • Font-Nieves M., Sans-Fons M. G., Gorina R., Bonfill-Teixidor E., Salas-Pérdomo A., Márquez-Kisinousky L., Santalucia T. and Planas A. M. (2012) Induction of COX-2 enzyme and down-regulation of COX-1 expression by lipopolysaccharide (LPS) control prostaglandin E2 production in astrocytes. J. Biol. Chem. 287, 64546468.
  • Gaestel M. and Kracht M. (2009) Peptides as signaling inhibitors for mammalian MAP kinase cascades. Curr. Pharm. Des. 15, 24712480.
  • Gaestel M., Kotlyarov A. and Kracht M. (2009) Targeting innate immunity protein kinase signalling in inflammation. Nat. Rev. Drug Discov. 8, 480499.
  • Gilroy D. W., Lawrence T., Perretti M. and Rossi A. G. (2004) Inflammatory resolution: new opportunities for drug discovery. Nat. Rev. Drug Discov. 3, 401416.
  • Gurley C., Nichols J., Liu S., Phulwani N. K., Esen N. and Kielian T. (2008) Microglia and astrocyte activation by toll-like receptor ligands: modulation by PPAR-gamma agonists. PPAR Res. 2008, 453120.
  • Hall M. G., Quignodon L. and Desvergne B. (2008) Peroxisome proliferator-activated receptor β/δ in the brain: facts and hypothesis. PPAR Res. 2008, 780452.
  • Hansen J. B., Zhang H., Rasmussen T. H., Petersen R. K., Flindt E. N. and Kristiansen K. (2001) Peroxisome proliferator-activated receptor δ (PPARδ)-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling. J. Biol. Chem. 276, 31753182.
  • Heneka M. T. and Landreth G. E. (2007) PPARs in the brain. Biochim. Biophys. Acta 1771, 10311045.
  • Hershko D. D., Robb B. W., Wray C. J., Luo G. J. and Hasselgren P. O. (2004) Superinduction of IL-6 by cycloheximide is associated with mRNA stabilization and sustained activation of p38 map kinase and NF-κB in cultured caco-2 cells. J. Cell. Biochem. 91, 951961.
  • Ikeda H., Kiritoshi T. and Murase K. (2012) Contribution of microglia and astrocytes to the central sensitization, inflammatory and neuropathic pain in the juvenile rat. Mol. Pain 8, 43.
  • Kaminska B., Gozdz A., Zawadzka M., Ellert-Miklaszewska A. and Lipko M. (2009) MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target. Anat. Rec. (Hoboken) 292, 19021913.
  • Kaplan J. M., Hake P. W., Denenberg A., Nowell M., Piraino G. and Zingarelli B. (2010) Phosphorylation of extracellular signal-regulated kinase (ERK)-1/2 Is associated with the downregulation of peroxisome proliferator-activated receptor (PPAR)-γ during polymicrobial sepsis. Mol. Med. 16, 491497.
  • Krogsdam A. M., Nielsen C. A., Neve S., Holst D., Helledie T., Thomsen B., Bendixen C., Mandrup S. and Kristiansen K. (2002) Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor δ-mediated transactivation. Biochem. J. 363, 157165.
  • Morrison D. C. and Jacobs D. M. (1976) Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry 13, 813818.
  • Newton R., Stevens D. A., Hart L. A., Lindsay M., Adcock I. M. and Barnes P. J. (1997) Superinduction of COX-2 mRNA by cycloheximide and interleukin-1β involves increased transcription and correlates with increased NF-κB and JNK activation. FEBS Lett. 418, 135138.
  • van Noort J. M. and Bsibsi M. (2009) Toll-like receptors in the CNS: implications for neurodegeneration and repair. Prog. Brain Res. 175, 139148.
  • Ozog M. A., Bernier S. M., Bates D. C., Chatterjee B., Lo C. W. and Naus C. C. (2004) The complex of ciliary neurotrophic factor-ciliary neurotrophic factor receptor alpha up-regulates connexin43 and intercellular coupling in astrocytes via the Janus tyrosine kinase/signal transducer and activator of transcription pathway. Mol. Biol. Cell 15, 47614774.
  • Pedras-Vasconcelos J., Puig M. and Verthelyi D. (2009) TLRs as therapeutic targets in CNS inflammation and infection. Front. Biosci. (Elite Ed) 1, 476487.
  • Pierce J. W., Schoenleber R., Jesmok G., Best J., Moore S. A., Collins T. and Gerritsen M. E. (1997) Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 272, 2109621103.
  • Rivest S. (2009) Regulation of innate immune responses in the brain. Nat. Rev. Immunol. 9, 429439.
  • Rypka M. and Vesely J. (2010) Evidence for differential effects of glucose and cycloheximide on mRNA levels of peroxisome proliferator-activated receptor- (PPAR-) machinery members: Superinduction of PPAR-γ1 and -γ2 mRNAs. Acta Biochim. Pol. 57, 209215.
  • Schnegg C. I. and Robbins M. E. (2011) Neuroprotective mechanisms of PPARδ: modulation of oxidative stress and inflammatory processes. PPAR Res. 2011, 373560.
  • Shao B., Li C., Yang H., et al. (2011) The relationship between Src-suppressed C kinase substrate and β-1,4 galactosyltransferase-I in the process of lipopolysaccharide-induced TNF-α secretion in rat primary astrocytes. Cell. Mol. Neurobiol. 31, 10471056.
  • Siegel M. R. and Sisler H. D. (1963) Inhibition of protein synthesis in Vitro by cycloheximide. Nature 200, 675676.
  • Steelman A. J., Smith R., 3rd, Welsh C. J. and Li J. (2013) Galectin-9 protein is up-regulated in astrocytes by tumor necrosis factor and promotes encephalitogenic T-cell apoptosis. J. Biol. Chem. 288, 2377623787.
  • Storm D. R., Rosenthal K. S. and Swanson P. E. (1977) Polymyxin and related peptide antibiotics. Annu. Rev. Biochem. 46, 723763.
  • Strokin M., Sergeeva M. and Reiser G. (2003) Docosahexaenoic acid and arachidonic acid release in rat brain astrocytes is mediated by two separate isoforms of phospholipase A2 and is differently regulated by cyclic AMP and Ca2+. Br. J. Pharmacol. 139, 10141022.